These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28809862)

  • 41. Comparative analysis of the GNAQ, GNA11, SF3B1, and EIF1AX driver mutations in melanoma and across the cancer spectrum.
    Johnson DB; Roszik J; Shoushtari AN; Eroglu Z; Balko JM; Higham C; Puzanov I; Patel SP; Sosman JA; Woodman SE
    Pigment Cell Melanoma Res; 2016 Jul; 29(4):470-3. PubMed ID: 27089234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
    Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
    PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
    Nell RJ; Menger NV; Versluis M; Luyten GPM; Verdijk RM; Madigan MC; Jager MJ; van der Velden PA
    BMC Cancer; 2021 Feb; 21(1):164. PubMed ID: 33588787
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutation scanning of BRAF, NRAS, KIT, and GNAQ/GNA11 in oral mucosal melanoma: a study of 57 cases.
    Lyu J; Wu Y; Li C; Wang R; Song H; Ren G; Guo W
    J Oral Pathol Med; 2016 Apr; 45(4):295-301. PubMed ID: 26399561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma.
    Bauer J; Kilic E; Vaarwater J; Bastian BC; Garbe C; de Klein A
    Br J Cancer; 2009 Sep; 101(5):813-5. PubMed ID: 19654573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles.
    Posch C; Latorre A; Crosby MB; Celli A; Latorre A; Vujic I; Sanlorenzo M; Green GA; Weier J; Zekhtser M; Ma J; Monico G; Char DH; Jusufbegovic D; Rappersberger K; Somoza Á; Ortiz-Urda S
    Biomed Microdevices; 2015 Feb; 17(1):15. PubMed ID: 25653058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.
    Mori T; Sukeda A; Sekine S; Shibata S; Ryo E; Okano H; Suzuki S; Hiraoka N
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5445-5451. PubMed ID: 29059311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers.
    Parish AJ; Nguyen V; Goodman AM; Murugesan K; Frampton GM; Kurzrock R
    Cancer; 2018 Oct; 124(20):4080-4089. PubMed ID: 30204251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GNA11 joins GNAQ and GNA14 as a recurrently mutated gene in anastomosing hemangioma.
    Liau JY; Tsai JH; Lan J; Chen CC; Wang YH; Lee JC; Huang HY
    Virchows Arch; 2020 Mar; 476(3):475-481. PubMed ID: 31707589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Copper ionophore elesclomol selectively targets GNAQ/11-mutant uveal melanoma.
    Li Y; Yang J; Zhang Q; Xu S; Sun W; Ge S; Xu X; Jager MJ; Jia R; Zhang J; Fan X
    Oncogene; 2022 Jul; 41(27):3539-3553. PubMed ID: 35697803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GNAQ
    Urtatiz O; Cook C; Huang JL; Yeh I; Van Raamsdonk CD
    Pigment Cell Melanoma Res; 2020 Jan; 33(1):96-111. PubMed ID: 31680437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research in practice: Therapeutic targeting of oncogenic GNAQ mutations in uveal melanoma.
    Gaffal E
    J Dtsch Dermatol Ges; 2020 Nov; 18(11):1245-1248. PubMed ID: 32954611
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells.
    Ambrosini G; Sawle AD; Musi E; Schwartz GK
    Oncotarget; 2015 Oct; 6(32):33397-409. PubMed ID: 26397223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chromosomal rearrangements in uveal melanoma: Chromothripsis.
    van Poppelen NM; Yavuzyigitoglu S; Smit KN; Vaarwater J; Eussen B; Brands T; Paridaens D; Kiliç E; de Klein A
    Genes Chromosomes Cancer; 2018 Sep; 57(9):452-458. PubMed ID: 29726589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase C inhibitors sensitize GNAQ mutant uveal melanoma cells to ionizing radiation.
    Cerne JZ; Hartig SM; Hamilton MP; Chew SA; Mitsiades N; Poulaki V; McGuire SE
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2130-9. PubMed ID: 24595385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Histopathologic and mutational analysis of a case of blue nevus-like melanoma.
    Dai J; Tetzlaff MT; Schuchter LM; Elder DE; Elenitsas R
    J Cutan Pathol; 2016 Sep; 43(9):776-80. PubMed ID: 27152652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas.
    Elbatsh AMO; Amin-Mansour A; Haberkorn A; Textor C; Ebel N; Renard E; Koch LM; Groenveld FC; Piquet M; Naumann U; Ruddy DA; Romanet V; Martínez Gómez JM; Shirley MD; Wipfli P; Schnell C; Wartmann M; Rausch M; Jager MJ; Levesque MP; Maira SM; Manchado E
    Nat Cancer; 2024 Mar; 5(3):481-499. PubMed ID: 38233483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK.
    Feng X; Arang N; Rigiracciolo DC; Lee JS; Yeerna H; Wang Z; Lubrano S; Kishore A; Pachter JA; König GM; Maggiolini M; Kostenis E; Schlaepfer DD; Tamayo P; Chen Q; Ruppin E; Gutkind JS
    Cancer Cell; 2019 Mar; 35(3):457-472.e5. PubMed ID: 30773340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blue nevi and variants: an update.
    Zembowicz A; Phadke PA
    Arch Pathol Lab Med; 2011 Mar; 135(3):327-36. PubMed ID: 21366456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.